when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

IGC Pharma, Inc. ($IGC) · catalysts · pharmadog

← back to IGC Pharma, Inc.

Catalysts for $IGC

651 tracked

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval

IGC Pharma, Inc.

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval

IGC Pharma, Inc.

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval

IGC Pharma, Inc.

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval

IGC Pharma, Inc.

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval

IGC Pharma, Inc.

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval

IGC Pharma, Inc.

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval

IGC Pharma, Inc.

Medinol, Ltd. — EluNIR Ridaforolimus Eluting Coronary Stent System (PMA supplement)

IGC Pharma, Inc.

LEO PHARMA INC recall (Cls II)

IGC Pharma, Inc.

Medinol, Ltd. — EluNIR Ridaforolimus Eluting Coronary Stent System (PMA supplement)

IGC Pharma, Inc.

GOLD STAR DISTRIBUTION INC recall (Cls II)

IGC Pharma, Inc.

OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

BUPRENORPHINE HYDROCHLORIDE — FDA approval

IGC Pharma, Inc.

PERCOCET (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

acetaminophen ER

OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

IGC Pharma, Inc.

← prevpage 1 of 22next →

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%

$IGC0.2670+0.41%